Internal Medicine, Endocrinology, Diabetes, & Metabolism · Zionsville, IN
NPI
1306823513
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6085 Heartland Dr Ste 204
Zionsville, IN, 46077
Phone (317) 873-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
3,536 services
Medicare patients, 2024
270
Average age 73
Drug cost, 2024
$1.8M
3,675 prescriptions
Company payments, 2025
$2,030
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn M Ayers was code 99214 (office e&m - established), 495 times for 229 patients. In total Dawn M Ayers billed 3,536 services in 16 codes, and Medicare paid $87K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 495 | 229 | $87.13 | $43K |
| 95251 Test - Miscellaneous | Office | 247 | 74 | $24.76 | $6,117 |
| 99213 Office E&M - Established | Office | 45 | 44 | $51.64 | $2,324 |
| 96372 Injection Administration | Office | 36 | 13 | $10.30 | $371 |
| 83036 Blood Count | Office | 33 | 26 | $9.52 | $314 |
By year: 2022 $68K for 1,736 services; 2023 $73K for 1,870 services; 2024 $87K for 3,536 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 33 | 26 | $9.52 | $314 |
Medicare prescription drug claims, 2024
In 2024, the drug Dawn M Ayers prescribed most often to Medicare patients was Levothyroxine Sodium, with 336 prescriptions and refills. In total Dawn M Ayers wrote 3,675 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 336 | 989 | 95 | $3,709 |
| Synthroid Levothyroxine Sodium | 335 | 873 | 81 | $35K |
| Mounjaro Tirzepatide | 186 | 285 | 27 | $305K |
| Metformin Hcl Er Metformin Hcl | 184 | 521 | 56 | $1,894 |
| Ozempic Semaglutide | 180 | 245 | 38 | $223K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 122 | 191 | 22 | $121K |
| Humalog Insulin Lispro | 99 | 161 | 21 | $27K |
| Humalog Kwikpen U-100 Insulin Lispro | 92 | 209 | 33 | $23K |
| Liothyronine Sodium Generic | 91 | 233 | 24 | $3,133 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 90 | 236 | 29 | $16K |
| Jardiance Empagliflozin | 85 | 220 | 24 | $130K |
| Atorvastatin Calcium Generic | 82 | 234 | 26 | $628 |
| Glimepiride Generic | 69 | 204 | 21 | $549 |
| Metformin Hcl Generic | 67 | 187 | 17 | $505 |
| Tresiba Flextouch U-100 Insulin Degludec | 59 | 154 | 20 | $57K |
Brand drugs: 1,856 claims; generic drugs: 1,495 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn M Ayers $2,030 ($2,030 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $325.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 26 | $325 |
| Novo Nordisk Inc NVO | 19 | $235 |
| Medtronic, Inc. MDT | 4 | $192 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $163 |
| Xeris Pharmaceuticals, Inc. | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Lilly USA, LLC LLY | 4 | $75.1 |
| Sequel Med Tech, LLC | 4 | $71.09 |
| Dexcom, Inc. DXCM | 3 | $61.74 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $60.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.